Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Oncogenic Role of MPHOSPH1, a Cancer-Testis Antigen Specific to Human Bladder Cancer

1 Apr 2007

Abstract excerpt

To disclose the molecular mechanism of bladder cancer, the second most common genitourinary tumor, we had previously done genome-wide expression profile analysis of 26 bladder cancers by means of cDNA microarray representing 27,648 genes. Among genes that were significantly up-regulated in the majority of bladder cancers, we here report identification of M-phase phosphoprotein 1 (MPHOSPH1) as a candidate molecule...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Peptidase Inhibition and Analysis
Share to RNA modifications and cancer
Share to Ubiquitin and proteasome pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 17409436
DOI: 10.1158/0008-5472.can-06-3748

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Oncogenic Role of MPHOSPH1, a Cancer-Testis Antigen Specific to Human Bladder CancerPMID 17409436Read ↗

Comprehensive Analysis of the role of DIAPH3 in Cancers and Validation in Bladder CancerSemantic proximity Read ↗

A pan-cancer analysis of the oncogenic role of protein regulator of cytokinesis 1(PRC1) in human tumorsSemantic proximity Read ↗

Evaluating the biological functions of the prognostic genes identified by the Pathology Atlas in bladder cancerSemantic proximity Read ↗

Identification of SPP1 as a Prognostic Biomarker and Immune Cells Modulator in Urothelial Bladder Cancer: A Bioinformatics AnalysisSemantic proximity Read ↗

ZFC3H1 provides a reference to evaluate the prognosis and treat prostate adenocarcinoma: A study based on TCGA dataSemantic proximity Read ↗

High PRMT5 expression is associated with poor overall survival and tumor progression in bladder cancerSemantic proximity Read ↗

Comprehensive analysis indicated that NDE1 is a potential biomarker for pan‐cancer and promotes bladder cancer progressionSemantic proximity Read ↗

Prognostic and chemotherapeutic response prediction by proliferation essential gene signature: Investigating POLE2 in bladder cancer progression and cisplatin resistanceSemantic proximity Read ↗

ARID1A-deficient bladder cancer is dependent on PI3K signaling and sensitive to EZH2 and PI3K inhibitorsSemantic proximity Read ↗

Characterization of PHGDH expression in bladder cancer: potential targeting therapy with gemcitabine/cisplatin and the contribution of promoter DNA hypomethylationSemantic proximity Read ↗

Overexpression of the ASPM gene is associated with aggressiveness and poor outcome in bladder cancerSemantic proximity Read ↗

Alterations of Histone H1 Phosphorylation During Bladder CarcinogenesisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.